drugset / Trial / NCT05938946
Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults
RandomizedSingle-groupDouble-blindTreatment
Summary
This is a Phase I, randomized, double-blinded, placebo-controlled single ascending dose, sequential-group study to evaluate the safety, tolerability, and PK of single ascending doses of L608 inhalation in healthy volunteers.
Timeline
- Start
- 2023-08-30
- Primary completion
- 2024-09-02
- Completion
- 2024-09-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L608 | Unknown | — | Inhaled |